Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
Benzinga
JUNE 11, 2023
Novartis to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of up to approximately $3.5 The transaction has been unanimously approved by the Boards of Directors of both companies. "We
40 
Let's personalize your content